BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 29780236)

  • 1. Pharmacokinetic comparison of a fixed-dose combination versus concomitant administration of fimasartan, amlodipine, and rosuvastatin using partial replicated design in healthy adult subjects.
    Oh M; Ghim JL; Park SE; Kim EY; Shin JG
    Drug Des Devel Ther; 2018; 12():1157-1164. PubMed ID: 29780236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic and bioequivalence study comparing a fimasartan/rosuvastatin fixed-dose combination with the concomitant administration of fimasartan and rosuvastatin in healthy subjects.
    Kang WY; Seong SJ; Ohk B; Gwon MR; Kim BK; Cho S; Shim WS; Lee KT; Kim EH; Yang DH; Lee HW; Yoon YR
    Drug Des Devel Ther; 2018; 12():3607-3615. PubMed ID: 30464392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic comparison of a fixed-dose combination versus concomitant administration of amlodipine, olmesartan, and rosuvastatin in healthy adult subjects.
    Oh M; Shin JG; Ahn S; Kim BH; Kim JY; Shin HJ; Shin HJ; Ghim JL
    Drug Des Devel Ther; 2019; 13():991-997. PubMed ID: 31114155
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of the Pharmacokinetics of Highly Variable Drugs in Healthy Subjects Using a Partial Replicated Crossover Study: A Fixed-Dose Combination of Fimasartan 120 mg and Atorvastatin 40 mg versus Separate Tablets.
    Hwang JG; Yu KS; Lee S
    Drug Des Devel Ther; 2020; 14():1953-1961. PubMed ID: 32546962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of drug interactions between fimasartan and rosuvastatin after single and multiple doses in healthy Caucasians.
    Lee J; Rhee SJ; Lee S; Yu KS
    Drug Des Devel Ther; 2018; 12():787-794. PubMed ID: 29670335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Pharmacokinetics of a Fixed-Dose Combination of Amlodipine/Losartan/Rosuvastatin with Concomitant Administration of Amlodipine/Losartan and Rosuvastatin in Healthy Volunteers.
    Yoon DY; Park SI; Jung JA; Kim YI; Jang IJ; Chung JY
    Drug Des Devel Ther; 2020; 14():661-668. PubMed ID: 32109991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic and bioequivalence study comparing a candesartan cilexetil/rosuvastatin calcium fixed-dose combination with the concomitant administration of candesartan cilexetil and rosuvastatin calcium in healthy Korean subjects
.
    Park DB; Jang K; Lee JW; Park CW; Lee BH; Kim MG; Jeon JY
    Int J Clin Pharmacol Ther; 2017 Mar; 55(3):286-294. PubMed ID: 28079517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic and bioequivalence study of a fixed-dose combination of amlodipine besylate and rosuvastatin calcium compared to co-administration of separate tablets in healthy Korean subjects
.
    Park JS; Jeon JY; Kim MG
    Int J Clin Pharmacol Ther; 2019 Dec; 57(12):612-622. PubMed ID: 31549624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative pharmacokinetics of a fixed-dose combination vs concomitant administration of telmisartan and S-amlodipine in healthy adult volunteers.
    Oh M; Park SE; Ghim JL; Choi YK; Shim EJ; Shin JG; Kim EY
    Drug Des Devel Ther; 2017; 11():3543-3550. PubMed ID: 29270003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic interactions between telmisartan/amlodipine and rosuvastatin after multiple oral administrations in healthy Korean male subjects.
    Moon SJ; Jeon JY; Jang K; Yu KS; Lim Y; Kim MG
    Drug Des Devel Ther; 2019; 13():2533-2542. PubMed ID: 31440035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic drug interaction study using fimasartan and rosuvastatin in healthy volunteers.
    Kang WY; Kim EH; Seong SJ; Gwon MR; Yang DH; Kim HJ; Lim MS; Lee HW; Yoon YR
    Int J Clin Pharmacol Ther; 2016 Dec; 54(12):992-1003. PubMed ID: 27668695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of rosuvastatin/olmesartan fixed-dose combination: a single-dose, randomized, open-label, 2-period crossover study in healthy Korean subjects.
    Son H; Roh H; Lee D; Chang H; Kim J; Yun C; Park K
    Clin Ther; 2013 Jul; 35(7):915-22. PubMed ID: 23810276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic interaction of fimasartan, a new angiotensin II receptor antagonist, with amlodipine in healthy volunteers.
    Yi S; Kim TE; Yoon SH; Cho JY; Shin SG; Jang IJ; Yu KS
    J Cardiovasc Pharmacol; 2011 Jun; 57(6):682-9. PubMed ID: 21394036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic and Pharmacodynamic Comparison of Two Formulations of a Fixed-Dose Combination of Gemigliptin/Rosuvastatin 50/20 mg: A Randomized, Open-Label, Single-Dose, Two-Way Crossover Study.
    Yang E; Yoo H; Jang IJ; Yu KS; Lee S
    Drug Des Devel Ther; 2021; 15():651-658. PubMed ID: 33628012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic comparison between fixed-dose combination of fimasartan/amlodipine 60/10 mg and the corresponding loose combination through partial replicated crossover study in healthy subjects.
    Yang E; Lee S; Lee H; Hwang I; Jang IJ; Yu KS; Lee S
    Transl Clin Pharmacol; 2019 Dec; 27(4):134-140. PubMed ID: 32095481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic Drug Interactions Between Amlodipine, Valsartan, and Rosuvastatin in Healthy Volunteers.
    Seong SJ; Ohk B; Kang WY; Gwon MR; Kim BK; Cho S; Yang DH; Lee HW; Yoon YR
    Adv Ther; 2019 Jul; 36(7):1642-1656. PubMed ID: 31119689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic comparison of 2 fixed-dose combination tablets of amlodipine and valsartan in healthy male Korean volunteers: a randomized, open-label, 2-period, single-dose, crossover study.
    Kim Y; Son M; Lee D; Roh H; Son H; Chae D; Bahng MY; Park K
    Clin Ther; 2013 Jul; 35(7):934-40. PubMed ID: 23870605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic comparison between a fixed-dose combination of fimasartan/amlodipine/hydrochlorothiazide 60/10/25 mg and a corresponding loose combination of fimasartan/amlodipine 60/25 mg and hydrochlorothiazide 25 mg in healthy subjects.
    Jung J; Lee S; Oh J; Lee S; Jang IJ; Lee D; Yu KS
    Transl Clin Pharmacol; 2021 Mar; 29(1):53-64. PubMed ID: 33855001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Pharmacokinetic Drug Interaction Between Fimasartan and Linagliptin in Healthy Volunteers.
    Kang WY; Lee HW; Gwon MR; Cho S; Shim WS; Lee KT; Yang DH; Seong SJ; Yoon YR
    Drug Des Devel Ther; 2020; 14():2101-2111. PubMed ID: 32546973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioequivalence Study of a New Fixed-dose Combination Tablet Containing S-Amlodipine Nicotinate and Olmesartan Medoxomil in Healthy Korean Male Subjects.
    Oh MJ; Hwang HH; Kim HG; Lee GH; Cho YS; Lee SY; Kang SY; Cho KH; Lee YY; Lee YJ; Jang CG; Lee SY
    Clin Ther; 2017 Jul; 39(7):1371-1379. PubMed ID: 28625505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.